» Articles » PMID: 25568072

Resident Memory T Cells in Human Health and Disease

Overview
Journal Sci Transl Med
Date 2015 Jan 9
PMID 25568072
Citations 210
Authors
Affiliations
Soon will be listed here.
Abstract

Resident memory T cells are non-recirculating memory T cells that persist long-term in epithelial barrier tissues, including the gastrointestinal tract, lung, skin, and reproductive tract. Resident memory T cells persist in the absence of antigens, have impressive effector functions, and provide rapid on-site immune protection against known pathogens in peripheral tissues. A fundamentally distinct gene expression program differentiates resident memory T cells from circulating T cells. Although these cells likely evolved to provide rapid immune protection against pathogens, autoreactive, aberrantly activated, and malignant resident memory cells contribute to numerous human inflammatory diseases including mycosis fungoides and psoriasis. This review will discuss both the science and medicine of resident memory T cells, exploring how these cells contribute to healthy immune function and discussing what is known about how these cells contribute to human inflammatory and autoimmune diseases.

Citing Articles

EXO1 is a key gene for lung-resident memory T cells and has diagnostic and predictive values for lung adenocarcinoma.

Li Z, Lin X, Yang Y, Tian M, Zhang L, Huang F Sci Rep. 2025; 15(1):4002.

PMID: 39893221 PMC: 11787328. DOI: 10.1038/s41598-025-88126-w.


BACH2-driven tissue resident memory programs promote HIV-1 persistence.

Wei Y, Ma H, Wong M, Papasavvas E, Konnikova L, Tebas P bioRxiv. 2025; .

PMID: 39763845 PMC: 11702684. DOI: 10.1101/2024.12.16.628794.


Magnesium-Phenolic Nanoeditor Refining Gliomatous T Cells for Metalloimmunotherapy.

Li W, Tian H, Yan Z, Yu X, Li B, Dai Y ACS Nano. 2024; 19(1):1222-1237.

PMID: 39701951 PMC: 11752515. DOI: 10.1021/acsnano.4c13388.


Mucosal Inflammatory Memory in Chronic Rhinosinusitis.

Koo M, Moon S, Rha M Cells. 2024; 13(23).

PMID: 39682698 PMC: 11639807. DOI: 10.3390/cells13231947.


Efficacy and Safety of Risankizumab in Patients with Psoriasis Showing Suboptimal Response to Secukinumab or Ixekizumab: Results from a Phase 3b, Open-Label, Single-Arm (aIMM) Study.

Warren R, Pavlovsky L, Costanzo A, Bukhalo M, Korman N, Huang Y Dermatol Ther (Heidelb). 2024; 14(12):3273-3290.

PMID: 39516454 PMC: 11604970. DOI: 10.1007/s13555-024-01292-z.


References
1.
Gebhardt T, Whitney P, Zaid A, Mackay L, Brooks A, Heath W . Different patterns of peripheral migration by memory CD4+ and CD8+ T cells. Nature. 2011; 477(7363):216-9. DOI: 10.1038/nature10339. View

2.
Mackay L, Rahimpour A, Ma J, Collins N, Stock A, Hafon M . The developmental pathway for CD103(+)CD8+ tissue-resident memory T cells of skin. Nat Immunol. 2013; 14(12):1294-301. DOI: 10.1038/ni.2744. View

3.
Neuber K, Schmidt S, Mensch A . Telomere length measurement and determination of immunosenescence-related markers (CD28, CD45RO, CD45RA, interferon-gamma and interleukin-4) in skin-homing T cells expressing the cutaneous lymphocyte antigen: indication of a non-ageing T-cell subset. Immunology. 2003; 109(1):24-31. PMC: 1782950. DOI: 10.1046/j.1365-2567.2003.01640.x. View

4.
Boyman O, Hefti H, Conrad C, Nickoloff B, Suter M, Nestle F . Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-alpha. J Exp Med. 2004; 199(5):731-6. PMC: 2213300. DOI: 10.1084/jem.20031482. View

5.
Mueller W, Herrmann B . Cyclosporin A for psoriasis. N Engl J Med. 1979; 301(10):555. DOI: 10.1056/NEJM197909063011016. View